-
公开(公告)号：EP3638302A1
公开(公告)日：2020-04-22
申请号：EP18749863.9
申请日：2018-06-14
-
公开(公告)号：EP3452087A1
公开(公告)日：2019-03-13
申请号：EP17733185.7
申请日：2017-05-01
发明人： BUNNIK, Evelien M. , CUSTERS, Jerome, H.h.v. , SCHEPER, Gerrit C. , KHAN, Selina , KALLA, Markus , WEIDNER, Katrin
IPC分类号： A61K39/12 , C07K14/025
-
公开(公告)号：EP3407910A1
公开(公告)日：2018-12-05
申请号：EP17702827.1
申请日：2017-01-27
申请人： Bavarian Nordic A/S
发明人： STEIGERWALD, Robin , KALLA, Markus
IPC分类号： A61K39/12 , C07K14/005 , C12N15/86
CPC分类号： A61K39/12 , A61K2039/5254 , A61K2039/5256 , A61K2039/545 , C07K14/005 , C12N15/86 , C12N2710/24143 , C12N2770/36134
摘要： The present invention relates to recombinant modified vaccinia virus Ankara (MVA) and to methods of using the same. In particular, the invention relates to recombinant MVA comprising a nucleotide sequence encoding for a structural protein of an equine encephalitis virus (EEV) excluding encoding for a capsid protein of the EEV, a composition in particular a pharmaceutical composition, a vaccine or kit comprising the recombinant MVA, uses and methods thereof e.g., suitable for treating and/or preventing a western, Venezuelan, and/or eastern equine encephalitis virus caused disease.
-
4.发明公开
公开(公告)号：EP4396333A1
公开(公告)日：2024-07-10
申请号：EP22772951.4
申请日：2022-09-02
申请人： Bavarian Nordic A/S
IPC分类号： C12N7/00
CPC分类号： C12N7/00 , C12N2710/2414120130101
-
公开(公告)号：EP3518964A2
公开(公告)日：2019-08-07
申请号：EP17783784.6
申请日：2017-09-28
申请人： Bavarian Nordic A/S
发明人： KALLA, Markus , ROUNTREE, Ryan , DIRMEIER, Ulrike
IPC分类号： A61K39/00 , C12N15/86 , C07K14/47 , C07K14/705
-
6.发明公开RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA (MVA) FOOT AND MOUTH DISEASE VIRUS (FMDV) VACCINE 审中-公开重组改造的痘苗病毒安卡拉（MVA）脚和口腔病毒（FMDV）疫苗
公开(公告)号：EP3307309A1
公开(公告)日：2018-04-18
申请号：EP16734206.2
申请日：2016-06-15
申请人： Bavarian Nordic A/S
发明人： STEIGERWALD, Robin , KALLA, Markus
IPC分类号： A61K39/12
CPC分类号： A61K39/12 , A61K9/0019 , A61K2039/552 , C12N2710/24034 , C12N2710/24143 , C12N2770/32134
摘要： The present invention relates to modified poxviral vectors and to methods of making and using the same. In particular, the invention relates to recombinant modified vaccinia virus Ankara-based (MVA-based) vaccine against FMDV infection and to related products, methods and uses. Specifically, the present invention relates to genetically engineered (recombinant) MVA vectors comprising at least one heterologous nucleotide sequence encoding an antigenic determinant of a FMDV protein. The invention also relates to products, methods and uses thereof, e.g., suitable to induce a protective immune response in a subject.
-
公开(公告)号：EP4117722A1
公开(公告)日：2023-01-18
申请号：EP21710330.8
申请日：2021-03-12
申请人： Bavarian Nordic A/S
发明人： KJAER, Katrine , KALLA, Markus
-
公开(公告)号：EP4061404A1
公开(公告)日：2022-09-28
申请号：EP20808119.0
申请日：2020-11-20
申请人： Bavarian Nordic A/S
-
公开(公告)号：EP4452306A1
公开(公告)日：2024-10-30
申请号：EP22844129.1
申请日：2022-12-23
申请人： Bavarian Nordic A/S
-
公开(公告)号：EP4452305A1
公开(公告)日：2024-10-30
申请号：EP22844103.6
申请日：2022-12-22
申请人： Bavarian Nordic A/S
发明人： HINTERBERGER, Maria , MEDINA ECHEVERZ, José , HABJAN, Matthias , HAUSMANN, Jürgen , KALLA, Markus , BERRAONDO LÓPEZ, Pedro
IPC分类号： A61K39/00 , A61K39/395 , A61P35/00 , C07K14/82 , C12N15/86 , C07K14/705
-
-
-
-
-
-
-
-
-
搜索结果
12 条记录 (耗时 0.012 秒)
